{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:56:23Z","timestamp":1792803383010,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":436,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41379-021-00868-w","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T12:02:40Z","timestamp":1625313760000},"page":"1966-1978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Takahiro","family":"Hongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-6445","authenticated-orcid":false,"given":"Hidetaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Jiromaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Yasumatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mioko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Wakasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00868-w_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrclinonc.2014.97","article-title":"Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances","volume":"11","author":"Llorente","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib2","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/cncr.28108","article-title":"Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009","volume":"119","author":"Ansa","year":"2013","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00868-w_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PAS.0000000000001566","article-title":"Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma","volume":"45","author":"Hongo","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12105-017-0779-0","article-title":"Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted Schneiderian papillomas","volume":"11","author":"Rooper","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/his.13732","article-title":"Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion","volume":"73","author":"Sasaki","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00868-w_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PAS.0000000000001410","article-title":"HPV-related sinonasal carcinoma: clinicopathologic features, diagnostic utility of p16 and Rb immunohistochemistry, and EGFR copy number alteration","volume":"44","author":"Jiromaru","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1097-0142(19920115)69:2<358::AID-CNCR2820690214>3.0.CO;2-1","article-title":"Clinical significance of the epidermal growth factor receptor gene in squamous cell carcinomas of the nasal cavities and paranasal sinuses","volume":"69","author":"Furuta","year":"1992","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00868-w_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/PAS.0b013e3182698673","article-title":"Human papillomavirus-related carcinomas of the sinonasal tract","volume":"37","author":"Bishop","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/0008-5472.CAN-15-2001","article-title":"Identification of the cell-intrinsic and -extrinsic pathways downstream of EGFR and IFN\u03b3 that induce PD-L1 expression in head and neck cancer","volume":"76","author":"Concha-Benavente","year":"2016","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00868-w_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oraloncology.2018.09.016","article-title":"The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"86","author":"Yang","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib11","doi-asserted-by":"crossref","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1038\/s41379-021-00868-w_bib12","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/CMAR.S201568","article-title":"Clinical relevance and significance of programmed death-ligand 1 expression, tumor-infiltrating lymphocytes, and p16 status in sinonasal squamous cell carcinoma","volume":"11","author":"Quan","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1038\/s41379-021-00868-w_bib13","doi-asserted-by":"crossref","first-page":"92699","DOI":"10.18632\/oncotarget.21564","article-title":"Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma","volume":"8","author":"Ono","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-021-00868-w_bib14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00868-w_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41379-020-00702-9","article-title":"Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes","volume":"34","author":"Yugawa","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1038\/s41379-021-00868-w_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/his.13646","article-title":"PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis\u2014impact on clinical outcome","volume":"73","author":"Schneider","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00868-w_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/s41379-021-00868-w_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/hed.25067","article-title":"Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer","volume":"40","author":"Riobello","year":"2018","journal-title":"Head Neck"},{"key":"10.1038\/s41379-021-00868-w_bib20","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/s41379-021-00868-w_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1038\/s41379-021-00868-w_bib23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1038\/s41379-021-00868-w_bib24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-021-00868-w_bib25","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00868-w_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Bonneville","year":"2017","journal-title":"Science"},{"key":"10.1038\/s41379-021-00868-w_bib27","doi-asserted-by":"crossref","unstructured":"Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017;2017:1\u201315.","DOI":"10.1200\/PO.17.00073"},{"key":"10.1038\/s41379-021-00868-w_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<410::AID-IJC14>3.0.CO;2-J","article-title":"Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma","volume":"84","author":"Blons","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-021-00868-w_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.otohns.2008.10.038","article-title":"Microsatellite instability analysis of sinonasal carcinomas","volume":"140","author":"Mart\u00ednez","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1038\/s41379-021-00868-w_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00868-w_bib31","unstructured":"Bishop JA, Bell D, Westra WH, Brandwein-Gensler M, Nicolai P, Steens S, et al. Tumors of the nasal cavity, paranasal sinuses and skull base. Carcinomas. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, eds. World Health Organization Classification of Tumors. Pathology and genetics of head and neck tumors. Lyon, France: IARC Press; 2017. p.14\u201327."},{"key":"10.1038\/s41379-021-00868-w_bib32","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C, Union for International Cancer Control TNM classification of malignant tumours, 2017, 8th ed., Chichester, UK, Wiley.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"10.1038\/s41379-021-00868-w_bib33","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, eds. Union for International Cancer Control TNM classification of malignant tumours, 7th ed. New York, NY: Wiley; 2009.","DOI":"10.1002\/9780471420194.tnmc26"},{"key":"10.1038\/s41379-021-00868-w_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/PAS.0000000000000947","article-title":"Clinicopathologic and molecular characteristics of synchronous colorectal carcinoma with mismatch repair deficiency","volume":"42","author":"Nakano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41379-019-0414-6","article-title":"Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes","volume":"33","author":"Hechtman","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-021-00868-w_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s10147-020-01829-0","article-title":"Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study","volume":"26","author":"Hanai","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41379-020-00710-9","article-title":"Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer","volume":"34","author":"Emancipator","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00868-w_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00868-w_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hed.26036","article-title":"Impact of PD-L1 expression and human papillomavirus status in anti-PD1\/PDL1 immunotherapy for head and neck squamous cell carcinoma-systematic review and meta-analysis","volume":"42","author":"Patel","year":"2020","journal-title":"Head Neck"},{"key":"10.1038\/s41379-021-00868-w_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1038\/s41379-021-00868-w_bib43","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-15-0340","article-title":"High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma","volume":"75","author":"Udager","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00868-w_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtho.2016.10.007","article-title":"Checkpoint inhibitors in metastatic EGFR-mutated non-small cell lung cancer-a meta-analysis","volume":"12","author":"Lee","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.12.003","article-title":"PD-L1 expression according to the EGFR status in primary lung adenocarcinoma","volume":"116","author":"Takada","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1038\/s41379-021-00868-w_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41591-018-0007-9","article-title":"Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer","volume":"24","author":"Robichaux","year":"2018","journal-title":"Nat Med"},{"key":"10.1038\/s41379-021-00868-w_bib47","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1200\/JCO.2019.37.15_suppl.9007","article-title":"Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions","volume":"37","author":"Janne","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib48","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hed.20857","article-title":"Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck","volume":"30","author":"Koy","year":"2008","journal-title":"Head Neck"},{"key":"10.1038\/s41379-021-00868-w_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/mdy507","article-title":"Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma","volume":"30","author":"Oliva","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-021-00868-w_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/path.4750","article-title":"Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma","volume":"239","author":"Udager","year":"2016","journal-title":"J Pathol"},{"key":"10.1038\/s41379-021-00868-w_bib51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas Network.","year":"2015","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00868-w_bib52","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.3390\/ijms131012153","article-title":"Prognostic and predictive roles of KRAS mutation in colorectal cancer","volume":"13","author":"Arrington","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1038\/s41379-021-00868-w_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2019.10.027","article-title":"The superior efficacy of anti-PD-1\/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity","volume":"470","author":"Liu","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1038\/s41379-021-00868-w_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS G12C inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00868-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00868-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200504X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200504X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00868-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:33:39Z","timestamp":1760229219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522200504X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S089339522200504X"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00868-w","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00868-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}